Global Galacto-Oligosaccharides Market 2025-2035

Description

List of Tables

Galacto-Oligosaccharides Market Size, Share & Trends Analysis Report by Form (Powder, Capsules, and Syrup), by Application (Eczema, Colic, Hay Fever, Food Allergies, Constipation, Obesity, and Other), by End-User (Food & Beverages and Dietary Supplement), by Distribution Channel (Online and Offline), Forecast Period (2026-2035)

Industry Overview

Galacto-Oligosaccharides market was valued at $1,981 million in 2025 and is projected to reach $4,689 million by 2035, growing at a CAGR of 9.0% during the forecast period (2026-2035). Galacto-Oligosaccharides (GOS) are prebiotics that are widely used in gut health management. The growing prevalence of gastrointestinal (GI) diseases such as IBS (irritable bowel syndrome), IBD (inflammatory bowel disease), constipation, and digestive discomfort is creating demand for galacto-oligosaccharides supplements. IBS is among the most common GI diseases and is prevalent in 5-10% of the population globally. IBS is common in people under the age of 50, other GI diseases, such as constipation and digestive discomfort, are common. Prebiotics like Galacto-oligosaccharides help enhance the symptoms of IBS by stimulating good gut bacteria like bifidobacteria. Most companies are adding galacto-oligosaccharides in supplements to enhance the overall health of the gut.

For instance, Clasado Biosciences, headquartered in Jersey, focused on the development of galacto-oligosaccharide products - Bimuno that target gut microbiome modulation and gut-mediated health disorders. Bimuno is a daily nutritional supplement that contains the B-GOS, which works in the gut to support symptoms like bloating and improve bowel regularity, and also supports cognitive and immune health by influencing the gut-brain axis and the immune system.

Market Dynamics

Gained Interest in Infant Nutrition Applications

Galacto-Oligosaccharides have gained interest as a functional food ingredient and are highly in demand in infant formulas. Galacto-Oligosaccharides, especially beta- Galacto-Oligosaccharides, have the potential to mimic some of the benefits of human milk oligosaccharides (HMOs) in breast milk. It supports the infant's gut health and potentially immune function. Several emerging players are entering the market with baby formula products fortified with GOS.

Enfamil NeuroPro, a Newborn and infant formula, has GOS, 2'-FL HMO, and PDX to offer immune support. The company offers multiple products focusing on brain health, gut health, and immune support in infants.
Aptamil Care Infant Formula also has Dual prebiotic GOS/FOS and its patented probiotic B. breve M-16V to help support the baby's immune system development and digestive health. It also contains DHA to help support brain & eye development and Key vitamins & minerals found in breast milk, including Vitamins C & D.

Surge in Functional Foods & Beverages

Functional foods are foods with more added health benefits than conventional foods. Functional foods offer numerous health advantages, such as weight control, mental function, and digestive health. Prebiotics like Galacto-Oligosaccharides do a host of things through supporting a healthy gut microbiome. It enhances digestion, mineral absorption, improves blood sugar levels, and improves the immune system. The increased awareness about functional foods, health consciousness, and the enhanced use of dietary supplements are driving demand for prebiotic products based on GOS. Additionally, the approval of the GSO Therapeutic application is also going to play an added role in functional food and beverages.

Recently, in July 2025, Clasado announced that Bimuno GOS can now be used in Therapeutic Goods Administration (TGA)-listed products in Australia, including supplements intended for therapeutic purposes.

Market Segmentation

Based on form, the market is segmented into powder, capsules, and syrup.
Based on application, the market is segmented into eczema, colic, hay fever, food allergies, constipation, obesity, and other conditions.
Based on end-user, the market is segmented into food & beverages and dietary supplements.
Based on by distribution channel, the market is segmented into online and offline.

Capsules are Considered the Primary GSO Forms

Galacto-Oligosaccharides capsules have many benefits and are considered one of the ways to deliver medicine and supplements. Capsules enhance the bioavailability of Galacto-Oligosaccharides because the capsule protects the Galacto-Oligosaccharides from the gastrointestinal tract's environment. Some companies sell Galacto-Oligosaccharides (GOS) in capsule form, including Megapre, GOSPrebio, Klaire Labs, SFI Health, and Pure Encapsulations. Some examples are:

Microbiome Labs MegaSporeBiotic - Spore probiotics for gastrointestinal health, designed for men and women.
Best Naturals Prebiotics Fiber XOS (Xylo Oligosaccharide) 1400 mg - A prebiotic supplement for intestinal health.
Klaire Labs SFI Health Galactomune - A prebiotic blend with Beta-Glucan and Galacto-oligosaccharides designed for immune support; soy- and gluten-free.

Regional Outlook

The global galacto-oligosaccharides product market has witnessed significant growth in major economies such as the US, UK, Germany, France, Spain, South Korea, Australia, New Zealand, and Canada. The primary growth driver for GOS supplements is the rising health-conscious population and increasing demand for dietary supplements. Furthermore, emerging markets such as India, China, Brazil, and Mexico have experienced considerable growth in the functional food and supplement market, creating additional opportunities for GOS prebiotics products.

Growing Demand for Functional Nutrition and Digestive Health in the Asia Pacific

Asia-Pacific galacto-oligosaccharides market is driven by growing awareness of functional nutrition and digestive health. Growing demand for infant formula with added prebiotics has created a good environment for market development. Yakult Honsha Co., Ltd. is helping facilitate this gain in the provision of GOS-formulated products designed to benefit gut microbiota. Additionally, dairy manufacturers that incorporate GOS into more value-added products have enhanced local adoption. Regulator's approvals in the main markets of Japan, China, and Australia are securing product authenticity, leading to stronger consumer assurance in emerging markets.

North America will account for the Largest Share of the Global GOS Market

North America, especially the US, is anticipated to hold the highest galacto-oligosaccharides product market share in 2024, driven by increasing consumer awareness of preventative health and demand for personalized nutrition and plant-based options. The US dietary supplement market has grown significantly from approximately 4,000 products in 1994 to an estimated 80,000 today. Around 80% of US consumers use dietary supplements daily. The study published by the Office of Dietary Supplements, National Institutes of Health, Bethesda, Maryland, from 1999 to 2018, showcased that one in 20 US adults or children uses nonfood pre-, pro-, or synbiotic products, and use has sharply increased in recent years. Most individuals voluntarily take these products for general digestive or overall health reasons.

Market Players Outlook

The major companies operating in the global galacto-oligosaccharides market include Danone S.A. (Nutricia), DSM-Firmenich AG, Fonterra Co-operative Group Ltd, FrieslandCampina group and International Flavors & Fragrances Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In April 2025, FrieslandCampina Ingredients, in protein and prebiotics, announced it had received 16 key health claim approvals from the Food Standards Australia New Zealand (FSANZ). The recent wave of approvals includes 12 approved health claims for its first-of-its-kind Biotis Fermentis ingredient for the active and sports nutrition market. Biotis GOS and Vivinal GOS have also been approved for claims relating to supporting iron and calcium absorption in both adults and children over one year old.
In January 2021, IFF launched the launch of Nurica enzyme in China, offering a new way for dairy producers to create a premium product to fulfil consumer health needs while increasing profitability. Nurica is IFF's latest innovation for the Chinese market and is marketed under the Danisco range of food ingredients that is now part of the IFF family.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global galacto-oligosaccharides market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2022588

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Galacto-Oligosaccharides Market Sales Analysis - Form | Application | End-User | Distribution Channel | ($ Million)
Galacto-Oligosaccharides Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Galacto-Oligosaccharides Industry Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Galacto-Oligosaccharides Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For Global Galacto-Oligosaccharides Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Galacto-Oligosaccharides Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - Galacto-Oligosaccharides Market Revenue and Share by Manufacturers
Galacto-Oligosaccharides Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Danone S.A. (Nutricia)
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. DSM-Firmenich AG
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Fonterra Co-operative Group Ltd.
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. FrieslandCampina group
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. International Flavors & Fragrances Inc.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Galacto-Oligosaccharides Market Sales Analysis by Form ($ Million)

5.1. Powder
5.2. Capsules
5.3. Syrup

6. Global Galacto-Oligosaccharides Market Sales Analysis by Application ($ Million)

6.1. Eczema
6.2. Colic
6.3. Hay Fever
6.4. Food Allergies
6.5. Constipation
6.6. Obesity
6.7. Other

7. Global Galacto-Oligosaccharides Market Sales Analysis by End-User ($ Million)

7.1. Food & Beverages
7.2. Dietary Supplement

8. Global Galacto-Oligosaccharides Market Sales Analysis by Distribution Channel ($ Million)

8.1. Online
8.2. Offline

9. Regional Analysis

9.1. North American Galacto-Oligosaccharides Market Sales Analysis - Form | Application | End-User | Distribution Channel | Country ($ Million)
Macroeconomic Factors for North America
- 9.1.1. United States
- 9.1.2. Canada
9.2. European Galacto-Oligosaccharides Market Sales Analysis - Form | Application | End-User | Distribution Channel | Country ($ Million)
Macroeconomic Factors for Europe
- 9.2.1. UK
- 9.2.2. Germany
- 9.2.3. Italy
- 9.2.4. Spain
- 9.2.5. France
- 9.2.6. Russia
- 9.2.7. Rest of Europe
9.3. Asia-Pacific Galacto-Oligosaccharides Market Sales Analysis - Form | Application | End-User | Distribution Channel | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.3.4. India
- 9.3.5. Australia & New Zealand
- 9.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 9.3.7. Rest of Asia-Pacific
9.4. Rest of the World Galacto-Oligosaccharides Market Sales Analysis - Form | Application | End-User | Distribution Channel | Country ($ Million)
Macroeconomic Factors for Rest of the World
- 9.4.1. Latin America
- 9.4.2. Middle East and Africa

10. Company Profiles

10.1. Alfa Chemistry
- 10.1.1. Quick Facts
- 10.1.2. Company Overview
- 10.1.3. Product Portfolio
- 10.1.4. Business Strategies
10.2. Aojing Biotechnology Co. Ltd. (Van Wankum Ingredients)
- 10.2.1. Quick Facts
- 10.2.2. Company Overview
- 10.2.3. Product Portfolio
- 10.2.4. Business Strategies
10.3. Aojing Biotechnology Co. Ltd. (Van Wankum Ingredients)
- 10.3.1. Quick Facts
- 10.3.2. Company Overview
- 10.3.3. Product Portfolio
- 10.3.4. Business Strategies
10.4. Baolingbao Biology Co., Ltd.
- 10.4.1. Quick Facts
- 10.4.2. Company Overview
- 10.4.3. Product Portfolio
- 10.4.4. Business Strategies
10.5. Clasado Ltd.
- 10.5.1. Quick Facts
- 10.5.2. Company Overview
- 10.5.3. Product Portfolio
- 10.5.4. Business Strategies
10.6. Creative Enzymes
- 10.6.1. Quick Facts
- 10.6.2. Company Overview
- 10.6.3. Product Portfolio
- 10.6.4. Business Strategies
10.7. Dairy Crest Ltd. (Saputo Dairy UK)
- 10.7.1. Quick Facts
- 10.7.2. Company Overview
- 10.7.3. Product Portfolio
- 10.7.4. Business Strategies
10.8. Danone S.A. (Nutricia)
- 10.8.1. Quick Facts
- 10.8.2. Company Overview
- 10.8.3. Product Portfolio
- 10.8.4. Business Strategies
10.9. DSM-Firmenich AG
- 10.9.1. Quick Facts
- 10.9.2. Company Overview
- 10.9.3. Product Portfolio
- 10.9.4. Business Strategies
10.10. EUROSERUM SAS
- 10.10.1. Quick Facts
- 10.10.2. Company Overview
- 10.10.3. Product Portfolio
- 10.10.4. Business Strategies
10.11. Fonterra Co-operative Group Ltd.
- 10.11.1. Quick Facts
- 10.11.2. Company Overview
- 10.11.3. Product Portfolio
- 10.11.4. Business Strategies
10.12. FrieslandCampina group
- 10.12.1. Quick Facts
- 10.12.2. Company Overview
- 10.12.3. Product Portfolio
- 10.12.4. Business Strategies
10.13. Ingredion Inc.
- 10.13.1. Quick Facts
- 10.13.2. Company Overview
- 10.13.3. Product Portfolio
- 10.13.4. Business Strategies
10.14. International Flavors & Fragrances Inc.
- 10.14.1. Quick Facts
- 10.14.2. Company Overview
- 10.14.3. Product Portfolio
- 10.14.4. Business Strategies
10.15. Kerry Group plc
- 10.15.1. Quick Facts
- 10.15.2. Company Overview
- 10.15.3. Product Portfolio
- 10.15.4. Business Strategies
10.16. Kowa Holdings America, Inc.
- 10.16.1. Quick Facts
- 10.16.2. Company Overview
- 10.16.3. Product Portfolio
- 10.16.4. Business Strategies
10.17. MEGMILK SNOW BRAND Co., Ltd.
- 10.17.1. Quick Facts
- 10.17.2. Company Overview
- 10.17.3. Product Portfolio
- 10.17.4. Business Strategies
10.18. New Francisco (Yunfu City) Biotechnology Co., Ltd.
- 10.18.1. Quick Facts
- 10.18.2. Company Overview
- 10.18.3. Product Portfolio
- 10.18.4. Business Strategies
10.19. Nutraceuticals Group Europe Ltd UK
- 10.19.1. Quick Facts
- 10.19.2. Company Overview
- 10.19.3. Product Portfolio
- 10.19.4. Business Strategies
10.20. Quantum Hi-Tech (Guangdong) Biological Co., Ltd.
- 10.20.1. Quick Facts
- 10.20.2. Company Overview
- 10.20.3. Product Portfolio
- 10.20.4. Business Strategies
10.21. Samyang Corp.
- 10.21.1. Quick Facts
- 10.21.2. Company Overview
- 10.21.3. Product Portfolio
- 10.21.4. Business Strategies
10.22. Taiwan Fructose Co., Ltd.
- 10.22.1. Quick Facts
- 10.22.2. Company Overview
- 10.22.3. Product Portfolio
- 10.22.4. Business Strategies
10.23. The National Chemical Co., Ltd.
- 10.23.1. Quick Facts
- 10.23.2. Company Overview
- 10.23.3. Product Portfolio
- 10.23.4. Business Strategies
10.24. Vilvi Group
- 10.24.1. Quick Facts
- 10.24.2. Company Overview
- 10.24.3. Product Portfolio
- 10.24.4. Business Strategies
10.25. Vitalus Nutrition Inc.
- 10.25.1. Quick Facts
- 10.25.2. Company Overview
- 10.25.3. Product Portfolio
- 10.25.4. Business Strategies
10.26. Wilmar Sugar Pty Ltd.
- 10.26.1. Quick Facts
- 10.26.2. Company Overview
- 10.26.3. Product Portfolio
- 10.26.4. Business Strategies
10.27. Yakult Pharmaceutical Industry Co., Ltd.
- 10.27.1. Quick Facts
- 10.27.2. Company Overview
- 10.27.3. Product Portfolio
- 10.27.4. Business Strategies